BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17623956)

  • 1. Serum cancer antigen 125 in patients with pleural effusions.
    How SH; Liam CK; Jamalludin AR; Chin SP; Zal AB
    Med J Malaysia; 2006 Dec; 61(5):558-63. PubMed ID: 17623956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation and tissue distribution of CA125 in patients with pleural effusion].
    Tomita Y
    Igaku Kenkyu; 1989 Nov; 59(3):90-6. PubMed ID: 2639592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions.
    Liam CK; Lim KH; Wong CM
    Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
    Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic efficiency of serum lipid-bound sialic acid level in malignant pleural effusions].
    Bektemür G; Ozer F; Kanat F; Imecik O
    Tuberk Toraks; 2003; 51(3):265-70. PubMed ID: 15143404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
    Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
    Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches in the diagnostic procedure of malignant pleural effusions.
    Terracciano D; Di Carlo A; Papa P; Cicalese M; Maietta P; Cecere C; Mariano A; Macchia V
    Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of serum CA125 in patients with tuberculous pleurisy].
    Nakanishi Y; Hiura K; Katoh O; Yamaguchi T; Kuroki S; Aoki Y; Yamada H
    Kekkaku; 1991 Aug; 66(8):525-30. PubMed ID: 1921093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-dimer levels in pleural effusions.
    Dikensoy O; Stathopoulos GT; Zhu Z; Light RW
    Respir Med; 2006 Aug; 100(8):1337-41. PubMed ID: 16427265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of biochemical tests in the diagnosis of exudative pleural effusions.
    Ernam D; Atalay F; Hasanoglu HC; Kaplan O
    Clin Biochem; 2005 Jan; 38(1):19-23. PubMed ID: 15607312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
    Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
    Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology and clinical implications of eosinophilic pleural effusions.
    Riantawan P; Bangpattanasiri K; Chaowalit P; Sangsayan P
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):655-9. PubMed ID: 10437974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
    Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
    Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleural cancer antigen-125 levels in benign and malignant pleural effusions.
    Choi WI; Qama D; Lee MY; Kwon KY
    Int J Tuberc Lung Dis; 2013 May; 17(5):693-7. PubMed ID: 23575338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural effusions: role of commonly available investigations.
    How SH; Chin SP; Zal AR; Liam CK
    Singapore Med J; 2006 Jul; 47(7):609-13. PubMed ID: 16810434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of leptin in tuberculous pleural effusions.
    Celik G; Kaya A; Poyraz B; Ciledag A; Elhan AH; Oktem A; Tozkoparan E; Ozkan M
    Int J Clin Pract; 2006 Nov; 60(11):1437-42. PubMed ID: 16669825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.